FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 13, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 13, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 36.8% of total US population have received at least 1 dose
• 22.7% of total US population are fully vaccinated
• 22.7% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Alaska: 30.4%
2. New Mexico: 29.8%
3. Maine: 29.6%
4. Rhode Island: 29.5%
5. Connecticut: 28.6%
2. New Mexico: 29.8%
3. Maine: 29.6%
4. Rhode Island: 29.5%
5. Connecticut: 28.6%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 31 297 614 confirmed cases
• 562 937 deaths
• 562 937 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 704 446
2. Texas: 2 832 461
3. Florida: 2 125 846
4. New York: 1 964 256
5. Illinois: 1 285 298
2. Texas: 2 832 461
3. Florida: 2 125 846
4. New York: 1 964 256
5. Illinois: 1 285 298
Deaths: California has the most deaths due to COVID-19 with 60 502 reported fatalities, followed by New York with 51 238, and Texas with 49 237.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 137 016 681 confirmed cases, 2 951 145 deaths, and 78 044 653 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
Advertisement
Advertisement
Trending on Patient Care Online
1
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
2
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
3
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5